![Jeroen Grasman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeroen Grasman
Finanzdirektor/CFO bei
VAXART, INC.
Vermögen: 351 915 $ am 31.05.2026
Profil
Jeroen Grasman is currently Chief Financial & Accounting Officer at Vaxart, Inc. since 2025.
Formerly, Mr. Grasman was Chief Financial Officer at AltruBio, Inc. from 2021 to 2025, Vice President-Finance & Operations at PACT Pharma, Inc. from 2018 to 2021, and Vice President-Finance at Intarcia Therapeutics, Inc. from 2016 to 2018.
Education includes graduate studies at the University of Groningen and an MBA from Harvard Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VAXART, INC. 0.23% | 19.05.2026 | 545’605 ( 0.23% ) | 351 915 $ | 31.05.2026 |
Aktive Positionen von Jeroen Grasman
| Unternehmen | Position | Beginn |
|---|---|---|
| VAXART, INC. | Finanzdirektor/CFO | 19.05.2025 |
Ehemalige bekannte Positionen von Jeroen Grasman
| Unternehmen | Position | Ende |
|---|---|---|
Altrubio, Inc.
 Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Finanzdirektor/CFO | 01.05.2025 |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Finanzdirektor/CFO | 01.08.2021 |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Finanzdirektor/CFO | 01.02.2018 |
Ausbildung von Jeroen Grasman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxart, Inc.
 Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
PACT Pharma, Inc.
PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Health Technology |
